Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Public ClinicalTrials.gov record NCT05329194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants With Severe Asthma Including Several Under-Studied Populations in the United States (PASSAGE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied populations in the United States.
Study identification
- NCT ID
- NCT05329194
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 286 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2022 (Actual)
- Primary completion
- Oct 1, 2025 (Actual)
- Completion
- Oct 1, 2025 (Actual)
- Last update posted
- Jul 16, 2026
2022 – 2025
United States locations
- U.S. sites
- 37
- U.S. states
- 25
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Long Beach | California | 90815 | — |
| Research Site | Los Angeles | California | 90017 | — |
| Research Site | Rancho Mirage | California | 92270 | — |
| Research Site | Westminster | California | 92683 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | New Haven | Connecticut | 06510 | — |
| Research Site | Washington D.C. | District of Columbia | 20037 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Lexington | Kentucky | 40509 | — |
| Research Site | New Orleans | Louisiana | 70112 | — |
| Research Site | Upper Marlboro | Maryland | 20772 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Ypsilanti | Michigan | 48197 | — |
| Research Site | Saint Paul | Minnesota | 55109 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Lincoln | Nebraska | 68505 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Hollis | New York | 11423 | — |
| Research Site | Horseheads | New York | 14845 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Valhalla | New York | 10595 | — |
| Research Site | Chapel Hill | North Carolina | 27514 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Toledo | Ohio | 43617 | — |
| Research Site | Oklahoma City | Oklahoma | 73120 | — |
| Research Site | Altoona | Pennsylvania | 16602 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Warwick | Rhode Island | 02886 | — |
| Research Site | Greenville | South Carolina | 29607 | — |
| Research Site | Hendersonville | Tennessee | 37075 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | McKinney | Texas | 75069 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Charlottesville | Virginia | 22903 | — |
| Research Site | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05329194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05329194 live on ClinicalTrials.gov.